PortfoliosLab logoPortfoliosLab logo
EW vs. MTD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EW vs. MTD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and Mettler-Toledo International Inc. (MTD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EW achieves a 2.83% return, which is significantly higher than MTD's -16.08% return. Over the past 10 years, EW has underperformed MTD with an annualized return of 9.98%, while MTD has yielded a comparatively higher 12.08% annualized return.


EW

1D
-0.57%
1M
4.38%
YTD
2.83%
6M
3.48%
1Y
12.24%
3Y*
0.90%
5Y*
-1.46%
10Y*
9.98%

MTD

1D
-1.15%
1M
-7.66%
YTD
-16.08%
6M
-19.15%
1Y
2.53%
3Y*
-4.25%
5Y*
-1.40%
10Y*
12.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EW vs. MTD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EW
Edwards Lifesciences Corporation
2.83%15.16%-2.91%2.20%-42.41%42.00%17.32%52.31%35.90%20.29%
MTD
Mettler-Toledo International Inc.
-16.08%13.93%0.88%-16.08%-14.83%48.92%43.67%40.26%-8.71%48.01%

Correlation

The correlation between EW and MTD is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.43

Correlation (10Y)
Calculated over the trailing 10-year period

0.45

Correlation (All Time)
Calculated using the full available price history since Mar 28, 2000

0.36

The correlation between EW and MTD shifts across timeframes, from 0.23 (1 year) to 0.45 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

EW:

$50.90B

MTD:

$23.73B

EPS

EW:

$1.87

MTD:

$42.68

PE Ratio

EW:

46.85

MTD:

27.41

PEG Ratio

EW:

1.51

MTD:

4.21

PS Ratio

EW:

8.12

MTD:

5.87

PB Ratio

EW:

4.93

MTD:

6.47

Total Revenue (TTM)

EW:

$6.30B

MTD:

$4.09B

Gross Profit (TTM)

EW:

$4.92B

MTD:

$2.36B

EBITDA (TTM)

EW:

$1.44B

MTD:

$1.24B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EW vs. MTD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW
EW Risk / Return Rank: 5656
Overall Rank
EW Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
EW Sortino Ratio Rank: 5252
Sortino Ratio Rank
EW Omega Ratio Rank: 4949
Omega Ratio Rank
EW Calmar Ratio Rank: 6060
Calmar Ratio Rank
EW Martin Ratio Rank: 6262
Martin Ratio Rank

MTD
MTD Risk / Return Rank: 4040
Overall Rank
MTD Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
MTD Sortino Ratio Rank: 3737
Sortino Ratio Rank
MTD Omega Ratio Rank: 3737
Omega Ratio Rank
MTD Calmar Ratio Rank: 4040
Calmar Ratio Rank
MTD Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EW vs. MTD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Mettler-Toledo International Inc. (MTD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EWMTDDifference

Sharpe ratio

Return per unit of total volatility

0.52

0.08

+0.44

Sortino ratio

Return per unit of downside risk

0.94

0.33

+0.62

Omega ratio

Gain probability vs. loss probability

1.11

1.04

+0.06

Calmar ratio

Return relative to maximum drawdown

0.95

0.04

+0.91

Martin ratio

Return relative to average drawdown

2.33

0.12

+2.21

EW vs. MTD - Sharpe Ratio Comparison

The current EW Sharpe Ratio is 0.52, which is higher than the MTD Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of EW and MTD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EWMTDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.52

0.08

+0.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.04

-0.04

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.31

0.41

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

0.52

0.53

-0.01

Drawdowns

EW vs. MTD - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum MTD drawdown of -61.43%. Use the drawdown chart below to compare losses from any high point for EW and MTD.


Loading charts...

Drawdown Indicators


EWMTDDifference

Max Drawdown

Largest peak-to-trough decline

-54.32%

-61.43%

+7.11%

Max Drawdown (1Y)

Largest decline over 1 year

-12.73%

-31.90%

+19.17%

Max Drawdown (3Y)

Largest decline over 3 years

-37.53%

-36.61%

-0.92%

Max Drawdown (5Y)

Largest decline over 5 years

-54.32%

-43.47%

-10.85%

Max Drawdown (10Y)

Largest decline over 10 years

-54.32%

-43.47%

-10.85%

Current Drawdown

Current decline from peak

-32.92%

-31.28%

-1.64%

Average Drawdown

Average peak-to-trough decline

-14.46%

-13.67%

-0.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.19%

10.71%

-5.52%

Volatility

EW vs. MTD - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 8.07%, while Mettler-Toledo International Inc. (MTD) has a volatility of 20.06%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than MTD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWMTDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.07%

20.06%

-11.99%

Volatility (6M)

Calculated over the trailing 6-month period

18.68%

26.08%

-7.40%

Volatility (1Y)

Calculated over the trailing 1-year period

23.84%

32.13%

-8.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.60%

32.14%

+0.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.24%

29.78%

+2.46%

Dividends

EW vs. MTD - Dividend Comparison

Neither EW nor MTD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

EW vs. MTD - Financials Comparison

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Mettler-Toledo International Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


800.00M1.00B1.20B1.40B1.60B20222023202420252026
1.65B
947.13M
(EW) Total Revenue
(MTD) Total Revenue
Values in USD except per share items

EW vs. MTD - Profitability Comparison

The chart below illustrates the profitability comparison between Edwards Lifesciences Corporation and Mettler-Toledo International Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20222023202420252026
78.2%
58.7%
Portfolio components
EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.

MTD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mettler-Toledo International Inc. reported a gross profit of 555.82M and revenue of 947.13M. Therefore, the gross margin over that period was 58.7%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.

MTD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mettler-Toledo International Inc. reported an operating income of 246.22M and revenue of 947.13M, resulting in an operating margin of 26.0%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.

MTD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mettler-Toledo International Inc. reported a net income of 169.45M and revenue of 947.13M, resulting in a net margin of 17.9%.


Frequently Asked Questions


EW and MTD have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MTD has higher volatility (20.06%) compared to EW (8.07%). In terms of maximum drawdown, EW dropped -54.32% vs MTD's -61.43%.

EW currently has the higher Sharpe Ratio (0.52 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EW and MTD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer